These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21087499)

  • 21. Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.
    Stahl A; Krohne TU; Eter N; Oberacher-Velten I; Guthoff R; Meltendorf S; Ehrt O; Aisenbrey S; Roider J; Gerding H; Jandeck C; Smith LEH; Walz JM;
    JAMA Pediatr; 2018 Mar; 172(3):278-286. PubMed ID: 29309486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis.
    Stritzke A; Kabra N; Kaur S; Robertson HL; Lodha A
    J Perinatol; 2019 Dec; 39(12):1584-1594. PubMed ID: 31570797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
    Early Treatment For Retinopathy Of Prematurity Cooperative Group
    Arch Ophthalmol; 2003 Dec; 121(12):1684-94. PubMed ID: 14662586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?
    Bührer C; Bassler D
    Neonatology; 2015; 108(1):49-52. PubMed ID: 25968340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis.
    Ortiz-Seller A; Martorell P; Roselló P; Morcillo E; Ortiz JL
    Paediatr Drugs; 2024 Sep; 26(5):499-518. PubMed ID: 39112827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial.
    Arima M; Inoue H; Misumi A; Tsukamoto S; Matsushita I; Araki S; Ohta M; Takahashi K; Imazato M; Goto T; Aoki Y; Tagawa K; Hirose M; Fujita Y; Yoshida N; Nakao S; Kondo H; Kusuhara K; Kimura K; Hasegawa S; Ikeda Y; Kodama Y; Moritake H; Ochiai M; Ohga S; Kishimoto J; Todaka K; Ieiri I; Sonoda KH
    Jpn J Ophthalmol; 2024 Sep; 68(5):490-499. PubMed ID: 39060675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.
    Uparkar M; Sen P; Rawal A; Agarwal S; Khan B; Gopal L
    Int Ophthalmol; 2011 Feb; 31(1):3-8. PubMed ID: 21194006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity.
    Dikopf MS; Machen LA; Hallak JA; Chau FY; Kassem IS
    J AAPOS; 2019 Aug; 23(4):211.e1-211.e6. PubMed ID: 31229607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression.
    Pascarella F; Scaramuzzo RT; Pini A; Cammalleri M; Bagnoli P; Ciantelli M; Filippi L
    Front Pediatr; 2024; 12():1322783. PubMed ID: 38292211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.
    Davitt BV; Dobson V; Quinn GE; Hardy RJ; Tung B; Good WV;
    Ophthalmology; 2009 Feb; 116(2):332-9. PubMed ID: 19091409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity.
    Arima M; Inoue H; Nakao S; Misumi A; Suzuki M; Matsushita I; Araki S; Yamashiro C; Takahashi K; Ochiai M; Yoshida N; Hirose M; Kishimoto J; Todaka K; Hasegawa S; Kimura K; Kusuhara K; Kondo H; Ohga S; Sonoda KH
    BMJ Open; 2021 Jul; 11(7):e047003. PubMed ID: 34315793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.
    Cavallaro G; Filippi L; Bagnoli P; La Marca G; Cristofori G; Raffaeli G; Padrini L; Araimo G; Fumagalli M; Groppo M; Dal Monte M; Osnaghi S; Fiorini P; Mosca F
    Acta Ophthalmol; 2014 Feb; 92(1):2-20. PubMed ID: 23617889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Repka MX; Palmer EA; Tung B
    Arch Ophthalmol; 2000 May; 118(5):645-9. PubMed ID: 10815156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity.
    Bai Y; Nie H; Wei S; Lu X; Ke X; Ouyang X; Feng S
    Br J Ophthalmol; 2019 Apr; 103(4):494-498. PubMed ID: 30030391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.
    Pediatrics; 2000 Feb; 105(2):295-310. PubMed ID: 10654946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2.
    Jalali S; Kesarwani S; Hussain A
    Am J Ophthalmol; 2011 Apr; 151(4):719-724.e2. PubMed ID: 21257156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
    Onofrey CB; Feuer WJ; Flynn JT
    Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.